维普期刊资源整合服务平台（V6.5）

21篇 您的检索式：作者名="Frew ME"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	The prensence of a FL T3 internal tandem duplicationin patients with acute myeloid leukemia addS important prognostic imformation to cytogenetic risk group and response to the first cycle of chemotherapy:analysis of 854 patients from the United Kingdom Medical Reserch Council AML 10 and 12 trials显示文摘	Kottaridis PD Gale RE Frew ME	2001	Blood2001，98，6：	1
2	The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy:Analysis of 854 patients from the united kingd显示文摘	Kottaridis PD Gale RE Frew ME	2001	Blood2001，，06：	1
3	The presence of a Flt3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenic risk group and response to the first cycle of chemotherapy:analysis of 854 patients from the United Kingdom Medical Reserch Council AML 10 and 12 trials显示文摘	Kottaridis PD Gale RE Frew ME	2001	Blood2001，98，6：	1
4	The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy:analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials显示文摘	Kottaridis PD Gale RE Frew ME	2001	Blood2001，98，6：	1
5	The presence ofa FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML)adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials显示文摘	Kottaridis PD Gale RE Frew ME	2001	Blood2001，98，6：	1
6	CYP1A1 * 2B (Val) allele is oven'epresented in a subgroup of acute myeloid leukemia patients with poor-risk karyotype associated with NRAS mutation, but not associated with FL33 internal tandem duplication 显示文摘	Bowen DT Frew ME Rollinson S	2003	Blood2003，101，7：	1
7	RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years显示文摘	Bowen DT Frew ME Hills R	2005	{H}Blood2005，，6：	1
8	The presence of a FLT3internal tandem duplication in patients with acute myeloid leuke mia (AML) adds important prognostic in显示文摘	Kottaridis PD Gale RE Frew ME	2001	Blood2001，98，6：	1
9	The presence of a FI,T3 internal tandem dupli- cation in patients with acute myeloid leukemia(AML) adds impor- tant prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy:analysis of 854 patients fi'om thc United Kingdom Medical Research Council AML 10 and 12 trials 显示文摘	Kottaridis PD Gale RE Frew ME Harrison G l angabeer SE Belton AA	2001	Blood2001，98，6：	1
10	The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy : analysis of 854 patients from the United Kingdom Medical Research Council AMLIO and 12 trials 显示文摘	KOTTARIDIS PD GALE RE FREW ME	2001	Blood2001，98，6：	1
11	The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials 显示文摘	Kottaridis PD Gale RE Frew ME	2001	Blood2001，98，6：	1
12	Aberrant methylation of the negative regulators RASSFIA SHP-1 and SOCS-1 in myelodysplastic syndromes and acute myeloid leukaemia显示文摘	Johan MF Bowen DT Frew ME	2005	Br J Haematol2005，129，1：	1
13	The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy:analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials显示文摘	Kottaridis PD Gale RE Frew ME	2001	Blood2001，98，：	1
14	The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia(AML)adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy:analysis of 854 patients from the United Kingdom Medical Research Council AML l0 and l2 trials显示文摘	Kottaridis PD Gale RE Frew ME et a1	2001	Blood2001，98，：	1
15	The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia(AML)adds important prognostic information to cytoge-netic risk group and response to the first cycle of chemotherapy:analysis of 854 patients from the United Kingdo显示文摘	Kottaridis PD Gale RE Frew ME	2001	{H}Blood2001，，06：	1
16	The presence ofa FLT3 internal tandem duplication in patients with acute myeloidleukemia (AML) adds important prognostic infomaation to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials 显示文摘	Kottaridis PD Gale RE Frew ME	2001	Blood2001，98，6：	1
17	The presence of a FL T3internal tandem uplication in patients with acute myeloid leukemia (AML)adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy:analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials显示文摘	Kottaridis PD Gale RE Frew ME	2001	Blood2001，98，10：	1
18	The presence of a FLT3 internal tandem duplication in patients with acute myeloid leuke- mia(AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy : analysis of 854 patients from the united kingdom medical research council AML 10 and 12 trials显示文摘	Kottaridis PD Gale RE Frew ME	2001	Blood2001，98，6：	1
19	The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials显示文摘	Kottaridis PD Gale RE Frew ME	2001	Blood2001，98，6：	1
20	The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy:analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials 显示文摘	Kottaridis PD Gale RE Frew ME	2001	Blood2001，98，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示